Galderma @ WCD 2023: Late-Breaking Phase III Results for Nemolizumab Monotherapy in Prurigo Nodularis Show a Significant Proportion of Itch-Free Patients by Week 4
Latest data from the phase III OLYMPIA 2 trial presented at the World Congress of…
Latest data from the phase III OLYMPIA 2 trial presented at the World Congress of…
Data demonstrate superiority vs. placebo in preventing generalized pustular psoriasis (GPP) flares up to 48…
SANYA, CHINA - Media OutReach - 4 July 2023 - VERTU, the world's premier luxury…
JOHANNESBURG, GAUTENG, ZA - Media OutReach - 4 July 2023 - The highly anticipated Digital…
BANGKOK, THAILAND - Media OutReach - 4 July 2023 - The <BTS EXHIBITION : Proof>…
KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO:6594; OTC US:NJDCY) (the “Company†or “Nidecâ€) today announced that it…
TAIPEI, Taiwan--(BUSINESS WIRE)--#InfoLink--InfoLink Consulting, a leading global renewable energy research consulting company, has released the…
Unique boutique fitness concept in Abu Dhabi a catalyst for transformation for many ABU DHABI,…
GENEVA, SWITZERLAND - Media OutReach - 4 July 2023 - On 3 July, the TRON…
Together, We Rise Again HONG KONG SAR - Media OutReach - 4 July 2023 -…